NCT07891702 Effect of Transcutaneous Electrical Stimulation on Polysomnographic Parameters in Patients With Obstructive Sleep Apnea
| NCT ID | NCT07891702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-07-06 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-07-06 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
* The aim of this study is to assess the impact of transcutaneous electrical stimulation on polysomnographic findings in obstructive sleep apnea patients. * The hypothesis of the present study is that nocturnal delivery of transcutaneous electrical stimulation of the pharyngeal dilators, in particular the genioglossus, may help in treating the functional loss of the neuromuscular tone with sleep onset to keep the Upper airway patent during sleep which would reduce the severity of OSA as measured by the apnea-hypopnea-index (AHI), so representing an alternative and better-tolerated approach compared to usual care with CPAP.
Eligibility Criteria
Inclusion Criteria: 1 - Adult patients aged 18 years or older. 2- Male or female patients diagnosed with obstructive sleep apnea by baseline overnight polysomnography. 3- Patients willing to participate in the study and provide written informed consent. Exclusion Criteria: 1. Patients with central sleep apnea or predominantly central sleep-disordered breathing. 2. Patients with significant unstable cardiovascular or respiratory disease that may increase the risk of participation. 3. Patients with implanted electronic devices, such as pacemakers or implantable cardioverter-defibrillators. 4. Patients with skin lesions, infection, irritation, or other abnormalities at the intended electrode application sites. 5. Patients with neurological or neuromuscular disorders that significantly affect upper airway muscle function. 6. Patients with a history of upper airway surgery that substantially alters upper airway anatomy, if this may interfere with study assessment. 7. Patients unable to tolerate electrical stimulation or complete the required polysomnography sessions. 8. Patients who decline to participate or withdraw their informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07891702 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07891702 currently recruiting?
Yes, NCT07891702 is actively recruiting participants. Contact the research team at dr_mshehta@mans.edu.eg for enrollment information.
Where is the NCT07891702 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07891702 clinical trial?
NCT07891702 is sponsored by Mansoura University. The trial plans to enroll 50 participants.